Skip to main content

Table 2 Clinical and demographic data of the patient cohort used in initial analysis

From: Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms

  N All Males Females Medulloblastoma ATRT Germinoma Controls Mean age (years) STDEV age Mean age (weeks) STDEV age
Initial analysis ALL 32        6.15 4.74 331.14 227.61
  MALES 22        8.41 4.98 439.46 238.84
  FEMALES 10        4.12 3.42 233.65 164.39
  UNKNOWN GENDER 0        NaN NaN NaN NaN
  MEDULLOBLASTOMA 15 8 7      7.13 4.62 378.41 221.92
  ATRT 4 1 3      2.46 3.06 153.90 146.95
  GERMINOMA 0 0 0      NaN NaN NaN NaN
  CONTROLS 13 13 0      NaN NaN NaN NaN
  FETAL 0 0 0 0 0 0 0 NaN NaN NaN NaN
  INFANT 3 1 2 1 2 0 0 0.34 0.30 52.53 14.18
  CHILD 13 5 8 11 2 0 0 5.80 3.44 314.59 165.35
  ADOLESCENT 3 3 0 3 0 0 0 13.45 1.85 681.48 88.71
  ADULT 0 0 0 0 0 0 0 NaN NaN NaN NaN
  % ALL MALES FEMALES MEDULLOBLASTOMA ATRT GERMINOMA CONTROLS     
  ALL 100.00%           
  MALES 68.75%           
  FEMALES 31.25%           
  UNKNOWN GENDER 0.00%           
  MEDULLOBLASTOMA 46.88% 4.97% 4.35%         
  ATRT 12.50% 0.62% 1.86%         
  GERMINOMA 0.00% 0.00% 0.00%         
  CONTROLS 40.63% 8.07% 0.00%         
  FETAL 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%     
  INFANT 9.38% 0.62% 1.24% 0.62% 1.24% 0.00% 0.00%     
  CHILD 40.63% 3.11% 4.97% 6.83% 1.24% 0.00% 0.00%     
  ADOLESCENT 9.38% 1.86% 0.00% 1.86% 0.00% 0.00% 0.00%     
  ADULT 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%